Skip to main content

Table 1 Evidence for the use of BoNT-A in chronic pain conditions

From: Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia

Condition

Subjects

Studies

Comparator

Outcomea

Ref.

EM

1838

9

Placebo

n.s.

18

CM

1508

5

Placebo

HEPM: −2.30 [95% CI: −3.7, −0.9]

18

59

1

Topiramate

n.s.

18

72

1

Amitriptyline

n.s.

18

CDH

1115

1

Placebo

HEPM: −2.1 [95% CI: −3.6, −0.6]

18

Any TTH

59

1

Valproate

n.s.

18

21

1

Steroids

HEPM: −2.5 [95% CI:−3.5, −1.5]

18

Chronic TTH

675

7

Placebo

n.s.

18

TMD

145

4

Placebo

Meta-analysis not performed

22

30

1

Manipulation

n.s.

22

CNPb

371

8

Placebo

Little or no difference

23

CCH

32

1

Placebo

Little or no difference

23

Whiplash

96

3

Placebo

n.s.

24

TN

178

4

Placebo

PPD: −29.8 [95% CI:−38.5, −21.1]

8

Diabetic NP

76

2

Placebo

0–10 VAS: −2.0 [95% CI:−3.1, −0.8]

27

Peripheral NP

68

1

Placebo

0–10 NRS:-0.8 [95% CI:−1.0, −0.6]

26

Spinal NP

40

1

Placebo

Significant VAS reduction

28

Myofascial

332

8

Placebo

n.s.

24

PSSP

86

5

Placebo

0–10 VAS: −1.2 [95% CI:−2.4, −0.1]

29

ASP

40

1

Placebo

0–10 VAS −2.0 [95% CI:−3.7, −0.3]

29

LE

274

4

Placebo

ES: −0.5 [95% CI:−0.9, −0.1]

31

LBP

131

3

Mixedc

Meta-analysis not performed

33

Ankle OA

75

1

HA

n.s.

34

PF

133

3

Placebo

n.s.

35

136

2

Steroids

Pain relief: −0.7 [95% CI:−1.0, −0.3]

35

BPS

317

6

Placebo

0–10 VAS −1.7 [95% CI:−3.2, −0.3]

38

  1. Here are reported chronic pain conditions for which at least one meta-analysis or systematic review was available. ASP Arthritic shoulder pain, BoNT-A Botulinum neurotoxin type A, BPS Bladder pain syndrome, CCH Chronic cervicogenic headache, CDH Chronic daily headache, CI Confidence interval, CM Chronic migraine, CNP Chronic neck pain, EM Episodic migraine, ES Effect size, HA Hyaluronic acid, HEPM Headache episodes per months, LBP Low back pain, LE Lateral epycondylitis, NP Neuropathic pain, NRS Numerical rating scale, n.s. Not significant, OA Osteoarthritis, PF Plantar fasciitis, PPD Paroxysms per day, PSSP Post-stroke shoulder pain, TMD Temporomandibular disorders, TN Trigeminal neuralgia, TTH Tension type headache, VAS Visual analogue scale
  2. aResults of the comparison between BoNT and comparator
  3. bPhysiotherapeutic exercise and analgesics were combined with both BoNT and placebo in two studies (n = 95 patients)
  4. cPlacebo, acupuncture or steroids